Andrew Joseph Zosel - 01 Mar 2026 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP, Chief Prod & Tech Officer
Signature
/s/ Elizabeth C. Radigan, Attorney-in-fact for Andrew Joseph Zosel
Issuer symbol
DBD
Transactions as of
01 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 17:50:09 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zosel Andrew Joseph EVP, Chief Prod & Tech Officer C/O DIEBOLD NIXDORF, INCORPORATED, 350 ORCHARD AVENUE NE, NORTH CANTON /s/ Elizabeth C. Radigan, Attorney-in-fact for Andrew Joseph Zosel 17 Mar 2026 0002121521

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Stock Award +6,561 $0.000000* 6,561 01 Mar 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended, and vesting in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
F2 Number includes Restricted Stock Units.